New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
New drugs cross blood-brain barrier to slow progression and even reverse symptoms of Huntington's disease

New drugs cross blood-brain barrier to slow progression and even reverse symptoms of Huntington's disease

FEBRUARY 26, 2024byWeizmann Institute of ScienceCredit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-023-00020-yWeizmann Institute scientists have discovered two small molecules
Neurology March 25,2024
New drugs cross blood-brain barrier to slow progression and even reverse symptoms of Huntington's disease

New drugs cross blood-brain barrier to slow progression and even reverse symptoms of Huntington's disease

FEBRUARY 26, 2024byWeizmann Institute of ScienceCredit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-023-00020-yWeizmann Institute scientists have discovered two small molecules
Neurology March 25,2024
New compound shows early promise for treatment of Lou Gehrig's disease in preclinical models

New compound shows early promise for treatment of Lou Gehrig's disease in preclinical models

NOVEMBER 7, 2023by Jaclyn Dunne,Medical University of South CarolinaMitochondrial membrane rearrangements are critical in recruiting p17/PERMIT-CerS1 to mitochondria. Credit:Aging Cell&nbs
Breakthroughs March 25,2024
New compound shows early promise for treatment of Lou Gehrig's disease in preclinical models

New compound shows early promise for treatment of Lou Gehrig's disease in preclinical models

NOVEMBER 7, 2023by Jaclyn Dunne,Medical University of South CarolinaMitochondrial membrane rearrangements are critical in recruiting p17/PERMIT-CerS1 to mitochondria. Credit:Aging Cell&nbs
Breakthroughs March 25,2024
New recommendations make it easier for patients to give feedback on their health

New recommendations make it easier for patients to give feedback on their health

FEBRUARY 29, 2024byUniversity of BirminghamCredit: CC0 Public DomainPatients providing feedback on their health during research or in clinical practice could now find it less onerous, thanks to
Breakthroughs March 25,2024
New recommendations make it easier for patients to give feedback on their health

New recommendations make it easier for patients to give feedback on their health

FEBRUARY 29, 2024byUniversity of BirminghamCredit: CC0 Public DomainPatients providing feedback on their health during research or in clinical practice could now find it less onerous, thanks to
Breakthroughs March 25,2024
Newly developed inhibitor shows potential for prostate cancer

Newly developed inhibitor shows potential for prostate cancer

JANUARY 9, 2024byAlbert Ludwigs University of FreiburgIdentification of a bi-substrate inhibitor of KMT9.aChemical structure of compound1awith predicted binding mode.&nbs
Oncology March 25,2024
Newly developed inhibitor shows potential for prostate cancer

Newly developed inhibitor shows potential for prostate cancer

JANUARY 9, 2024byAlbert Ludwigs University of FreiburgIdentification of a bi-substrate inhibitor of KMT9.aChemical structure of compound1awith predicted binding mode.&nbs
Oncology March 25,2024
Novel approach improves heart failure outcomes in animal model

Novel approach improves heart failure outcomes in animal model

FEBRUARY 8, 2024by Ana María Rodríguez,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainIn 2020, heart failure affected about 6.5 million people in the U.S. and 23 million around the w
Cardiovascular Diseases March 25,2024
Novel approach improves heart failure outcomes in animal model

Novel approach improves heart failure outcomes in animal model

FEBRUARY 8, 2024by Ana María Rodríguez,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainIn 2020, heart failure affected about 6.5 million people in the U.S. and 23 million around the w
Cardiovascular Diseases March 25,2024
New study pinpoints why some injured kidneys do not heal

New study pinpoints why some injured kidneys do not heal

FEBRUARY 22, 2024byCedars-Sinai Medical CenterCredit: CC0 Public DomainCedars-Sinai investigators have discovered why some injured kidneys heal while others develop scarring that can lead to kid
Nephrology & Urology March 25,2024
New study pinpoints why some injured kidneys do not heal

New study pinpoints why some injured kidneys do not heal

FEBRUARY 22, 2024byCedars-Sinai Medical CenterCredit: CC0 Public DomainCedars-Sinai investigators have discovered why some injured kidneys heal while others develop scarring that can lead to kid
Nephrology & Urology March 25,2024
New findings suggest life span can be increased by making cells less efficient at producing energy

New findings suggest life span can be increased by making cells less efficient at producing energy

by Pennington Biomedical Research CenterChristopher Axelrod, Director, Integrated Physiology and Molecular Medicine Laboratory at Pennington Biomedical Research Center. Credit: PBRCA newstudy&nb
Breakthroughs March 25,2024
New findings suggest life span can be increased by making cells less efficient at producing energy

New findings suggest life span can be increased by making cells less efficient at producing energy

by Pennington Biomedical Research CenterChristopher Axelrod, Director, Integrated Physiology and Molecular Medicine Laboratory at Pennington Biomedical Research Center. Credit: PBRCA newstudy&nb
Breakthroughs March 25,2024
New study shows a role for cholesterol in pain perception

New study shows a role for cholesterol in pain perception

FEBRUARY 27, 2024byUniversity of FloridaA cell membrane is illustrated to show the surface in red. Blue objects are proteins, including ion channels, which can send electrical impulses into cell
Breakthroughs March 25,2024
New study shows a role for cholesterol in pain perception

New study shows a role for cholesterol in pain perception

FEBRUARY 27, 2024byUniversity of FloridaA cell membrane is illustrated to show the surface in red. Blue objects are proteins, including ion channels, which can send electrical impulses into cell
Breakthroughs March 25,2024
New data analysis supports hedonic overdrive model in high-fat diet-induced mice

New data analysis supports hedonic overdrive model in high-fat diet-induced mice

FEBRUARY 27, 2024byThe Obesity SocietyCredit: Pixabay/CC0 Public DomainHigh-fat diets cause obesity in male mice. The underlying mechanism, however, remains controversial. After assessing three
Diabetes & Endocrinology March 25,2024
New data analysis supports hedonic overdrive model in high-fat diet-induced mice

New data analysis supports hedonic overdrive model in high-fat diet-induced mice

FEBRUARY 27, 2024byThe Obesity SocietyCredit: Pixabay/CC0 Public DomainHigh-fat diets cause obesity in male mice. The underlying mechanism, however, remains controversial. After assessing three
Diabetes & Endocrinology March 25,2024
New trial highlights incremental progress towards a cure for HIV-1

New trial highlights incremental progress towards a cure for HIV-1

FEBRUARY 13, 2024byUniversity of North Carolina School of MedicineLymphocyte with HIV cluster. Credit: Unsplash/CC0 Public DomainAntiretroviral therapies (ART) stop HIV replication in its tracks
Breakthroughs March 25,2024
New trial highlights incremental progress towards a cure for HIV-1

New trial highlights incremental progress towards a cure for HIV-1

FEBRUARY 13, 2024byUniversity of North Carolina School of MedicineLymphocyte with HIV cluster. Credit: Unsplash/CC0 Public DomainAntiretroviral therapies (ART) stop HIV replication in its tracks
Breakthroughs March 25,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com